Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

FLT3

Items 1-10 of 19

Page
per page
  1. UNC2025
    B8016 UNC2025
     1 Citation
    Target: MER|FLT3
    Summary: orally bioavailable dual MER/FLT3 inhibitor
      ≥23.85 mg/mL
  2. Tandutinib (MLN518) HCl
    B7853 Tandutinib (MLN518) HCl
    Summary: FLT3 inhibitor,potent and selective
      ≥59.9 mg/mL
  3. SU5614
    B6097 SU5614
     1 Citation
    Summary: tyrosine kinase inhibitor
      ≥27.3 mg/mL
  4. 5'-Fluoroindirubinoxime
    B5516 5'-Fluoroindirubinoxime
    Summary: FMS-like receptor tyrosine kinase-3 (FLT3) inhibitor
      <29.53 mg/mL
  5. Tandutinib (MLN518)
    B1526 Tandutinib (MLN518)
    Summary: FLT3 inhibitor,potent and selective
      ≥17.85 mg/mL
  6. G-749
    A8889 G-749
    Target: Aurora Kinases|FLT3|c-RET
    Summary: FLT3 inhibitor
      ≥26.05 mg/mL
  7. Quizartinib (AC220)
    A5793 Quizartinib (AC220)
    Target: FLT3
    Summary: FLT3 inhibitor,potent and selective
      ≥28.03 mg/mL
  8. Ponatinib (AP24534)
    A5467 Ponatinib (AP24534)
     1 Citation
    Target: VEGFR|PDGFR|Bcr-Abl|FGFR|Src
    Summary: pan-BCR-ABL inhibitor,multi-kinase inhibitor
      ≥53.3 mg/mL
  9. Lestaurtinib
    A4513 Lestaurtinib
     1 Citation
    Summary: JAK2/FLT3/TrkA inhibitor
      Soluble in DMSO
  10. Amuvatinib (MP-470, HPK 56)
    A4237 Amuvatinib (MP-470, HPK 56)
    Summary: Tyrosine kinase inhibitor
      ≥22.4 mg/mL

Items 1-10 of 19

Page
per page